A shout-out to my UofA homeys
The University of Alberta (where I was studied) has been in the news lately over a potential breakthrough in fighting cancer. DCA, is a small compound that messes up glycolysis, that fast-growing tumors rely on to supply energy. When glycolysis is disrupted, the normally suppressed mitochondria are re-activated. The mitochondria can then trigger cell-apoptosis, the self-destruction the cell. This is possibly one reason why low-calorie, low-sugar intake has been shown to help slow down and in some cases reduce some cancers. Malignant tumors need a lot of glucose in order to grow. The problem with DCA is that it is not patentable — so no big pharmaceutical company will touch it, let alone spend millions running clinical trials. They can’t profit from it. DCA human trials are going to be publicly funded.
Once again big pharmaceuticals show their colours. Kudos, UofA. Thanks for the heads-up, Aaronski.
As one who is trying to trick his cancer into submission, this is great news. Wish I lived in Edmonton to volunteer for the trials.